BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37404825)

  • 1. Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer.
    Lu Y; Gu D; Zhao C; Sun Y; Li W; He L; Wang X; Kou Z; Su J; Guo F
    Front Immunol; 2023; 14():1160052. PubMed ID: 37404825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer.
    Li X; Wu D; Li Q; Gu J; Gao W; Zhu X; Yin W; Zhu R; Zhu L; Jiao N
    Physiol Genomics; 2024 Feb; 56(2):221-234. PubMed ID: 38073489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
    Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
    Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
    Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
    Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.
    Mouillet-Richard S; Cazelles A; Sroussi M; Gallois C; Taieb J; Laurent-Puig P
    Clin Cancer Res; 2024 Jun; 30(11):2351-2358. PubMed ID: 38564259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Ubink I; van Eden WJ; Snaebjornsson P; Kok NFM; van Kuik J; van Grevenstein WMU; Laclé MM; Sanders J; Fijneman RJA; Elias SG; Borel Rinkes IHM; Aalbers AGJ; Kranenburg O
    Br J Surg; 2018 Jan; 105(2):e204-e211. PubMed ID: 29341165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
    Haasnoot KJC; Backes Y; Moons LMG; Kranenburg O; Trinh A; Vermeulen L; Noë M; Tuynman JB; van Lent AUG; van Ginneken R; Seldenrijk CA; Raicu MG; Trumpi K; Ubink I; Milne AN; Boonstra JJ; Groen JN; Schwartz MP; Wolfhagen FHJ; Geesing JMJ; Ter Borg F; Brosens LAA; van Bergeijk J; Spanier BWM; de Vos Tot Nederveen Cappel WH; Kessels K; Seerden TCJ; Vleggaar FP; Offerhaus GJA; Siersema PD; Elias SG; Laclé MM;
    Mod Pathol; 2020 Dec; 33(12):2626-2636. PubMed ID: 32581367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
    Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
    World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by
    Strating E; Wassenaar E; Verhagen M; Rauwerdink P; van Schelven S; de Hingh I; Rinkes IB; Boerma D; Witkamp A; Lacle M; Fodde R; Volckmann R; Koster J; Stedingk K; Giesel F; de Roos R; Poot A; Bol G; Lam M; Elias S; Kranenburg O
    Br J Cancer; 2022 Jul; 127(1):145-155. PubMed ID: 35296803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
    Peters NA; Constantinides A; Ubink I; van Kuik J; Bloemendal HJ; van Dodewaard JM; Brink MA; Schwartz TP; Lolkema MPJK; Lacle MM; Moons LM; Geesing J; van Grevenstein WMU; Roodhart JML; Koopman M; Elias SG; Borel Rinkes IHM; Kranenburg O
    Front Oncol; 2022; 12():969855. PubMed ID: 36147916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Delineation of Colorectal Cancer Molecular Subtypes and Functional Profiles with a 62-Gene Panel.
    Bhukdee D; Nuwongsri P; Israsena N; Sriswasdi S
    Mol Cancer Res; 2023 Mar; 21(3):240-252. PubMed ID: 36490322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of platelets in the consensus molecular subtypes of colorectal cancer.
    Lam M; Roszik J; Kanikarla-Marie P; Davis JS; Morris J; Kopetz S; Menter DG
    Cancer Metastasis Rev; 2017 Jun; 36(2):273-288. PubMed ID: 28681242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.
    González-Montero J; Burotto M; Valenzuela G; Mateluna D; Buen-Abad F; Toro J; Barajas O; Marcelain K
    World J Clin Oncol; 2023 Oct; 14(10):409-419. PubMed ID: 37970108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma.
    Zheng H; Bai Y; Wang J; Chen S; Zhang J; Zhu J; Liu Y; Wang X
    Front Mol Biosci; 2021; 8():649363. PubMed ID: 33996905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.
    He Y; Dai X; Chen Y; Huang S
    Genet Res (Camb); 2022; 2022():1831211. PubMed ID: 35975176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analyses of consensus molecular subtype-dependent associations of
    Smeby J; Sveen A; Bergsland CH; Eilertsen IA; Danielsen SA; Eide PW; Hektoen M; Guren MG; Nesbakken A; Bruun J; Lothe RA
    ESMO Open; 2019; 4(3):e000523. PubMed ID: 31321083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.